China’s Hengrui Pharma will receive $300 million upfront under the agreement, which grants Denmark’s Novo Nordisk global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results